Skip to main content

RASS Score

The Richmond Agitation-Sedation Scale (RASS) is a standard ICU and emergency-care scale for quantifying mental arousal from severe agitation to deep sedation. It supports sedation titration, delirium workflows, and communication during serial neurologic checks.

Formula: Single-item ordinal scale from +4 (combative) to -5 (unarousable), based on bedside response to voice and physical stimulation.

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

How It Works

1

Observe patient behavior for 30 seconds

Begin RASS assessment by observing the patient for 30 seconds without stimulation. Document if spontaneous agitation behaviors are present: +4 = combative (violent, immediate danger to staff); +3 = very agitated (pulling lines/tubes, aggressive); +2 = agitated (frequent non-purposeful movement, fighting ventilator); +1 = restless (anxious, apprehensive, movements not aggressive). If none of these apply, proceed to the next step.

2

Verbally stimulate the patient

Call the patient's name and ask them to 'open your eyes and look at me.' Assess the response: sustained eye opening with eye contact >10 seconds = RASS 0 (alert and calm); eye opening with brief eye contact <10 seconds = RASS -1 (drowsy); any eye opening or movement to voice but no eye contact = RASS -2 (light sedation). If there is no response to verbal stimulation, proceed to physical stimulation.

3

Physically stimulate the patient if no verbal response

Apply physical stimulation: shoulder shaking or sternal rub. Any movement in response = RASS -3 (moderate sedation) or RASS -4 (deep sedation — differentiate by whether movement is purposeful toward stimulus vs. non-purposeful). Absolutely no response to physical stimulation = RASS -5 (unarousable). Document and communicate RASS value.

Who Uses the RASS Score

ICU Sedation Monitoring and Titration

ICU nurses

RASS is used every 2–4 hours (or per institutional protocol) to guide sedation titration to the target range (typically RASS 0 to -2). If RASS is deeper than target (e.g., -4 when targeting -2), reduce sedation infusion rate. If agitated (RASS +2), assess for pain first, then consider sedation increase or agent change.

Daily Sedation Interruption Trials

Intensivists

Daily spontaneous awakening trials (SAT) target RASS 0 — stopping sedation infusions to allow full arousal. RASS measures the depth of sedation before SAT initiation and tracks arousal during and after the trial. SAT paired with spontaneous breathing trials (SBT) reduces ventilator days and ICU length of stay.

Ventilator Weaning Protocol Guidance

Respiratory therapists

Successful ventilator weaning and extubation requires appropriate level of consciousness. RASS 0 to -1 is typically required for extubation readiness — the patient should be awake enough to protect the airway and follow commands. Patients at RASS -3 or deeper typically cannot be extubated safely.

CAM-ICU Prerequisite Assessment

ICU teams

RASS is always assessed before CAM-ICU. RASS -4/-5 = CAM-ICU cannot be performed. RASS -3 to +4 = CAM-ICU can be attempted. Documenting RASS alongside CAM-ICU provides complete sedation and delirium status in a single clinical entry.

PADIS Guideline Compliance Monitoring

Quality improvement teams

PADIS 2018 guidelines recommend targeting light sedation (RASS 0 to -2) in most ICU patients. Quality monitoring of documented RASS values and percent time at target sedation level is a key ICU quality metric. Regular RASS documentation audits identify sedation depth deviations and guideline compliance.

Family Communication About Sedation Level

Bedside nurses

RASS provides families with objective, standardized information about sedation level. 'Your family member is at RASS -2 — they briefly open their eyes when we call their name' is more precise and reassuring than 'they're sedated.' Communicating RASS trajectory (improving toward 0) conveys clinical progress.

Pro Tips

1

RASS is the recommended sedation tool in PADIS 2018 guidelines

PADIS 2018 guidelines (Pain, Agitation/Sedation, Delirium, Immobility, Sleep Disruption) recommend RASS and SAS (Sedation Agitation Scale) as the two validated sedation scales for routine ICU use. RASS has a 10-point scale (+4 to -5) compared to SAS's 7-point scale (1–7), providing finer gradation in sedation depth.

2

Target RASS 0 to -2 for most ICU patients — light sedation is preferred

Multiple trials (MENDS, SEDCOM, ABC trial) demonstrate that light sedation (RASS 0 to -2) compared to deep sedation (RASS -3 to -5) reduces ventilator days, ICU length of stay, delirium duration, and mortality. Target RASS 0 to -2 unless there is a specific indication for deeper sedation (status epilepticus, ARDS with neuromuscular blockade, severe ICP elevation).

3

Deep sedation (RASS -3 to -5) independently increases mortality

Shehabi et al. (JAMA 2012, SPICE study) demonstrated early deep sedation (RASS -3 or deeper within 48 hours of ICU admission) was independently associated with increased 180-day mortality after adjustment for severity. Every additional day of deep sedation increases mortality risk. Avoid deep sedation unless specifically indicated.

4

Daily SAT + SBT (ABC Bundle) reduces ventilator days by 2–3 days

Girard et al. (Lancet 2008, ABC trial) showed daily spontaneous awakening trials (SAT, targeting RASS 0) paired with spontaneous breathing trials (SBT) reduced time on ventilator by 2.4 days, ICU stay by 3.2 days, and 1-year mortality by 14%. This is the strongest evidence-based intervention in ICU sedation management.

5

Assess PAIN before escalating sedation in agitated patients (RASS +1 to +4)

Pain is one of the most common causes of agitation in ICU patients. Before increasing sedation in a RASS +1 or higher patient, always assess and treat pain first (CPOT assessment, analgesia trial). The analgesia-first approach reduces sedation requirements, delirium, and total opioid doses. Treating agitation with sedation before addressing pain is a common and harmful error.

6

Benzodiazepines are associated with more delirium than propofol or dexmedetomidine

Multiple observational and RCT data show benzodiazepine-based sedation (lorazepam, midazolam) is associated with significantly higher rates of ICU delirium compared to propofol or dexmedetomidine. Dexmedetomidine allows cooperative, arousable sedation (RASS 0 to -2) with analgesic properties, less respiratory depression, and fewer delirium-positive days in MENDS trial.

7

RASS +1 to +4: assess the cause before increasing sedation

Agitation causes to rule out before adding/increasing sedation: pain (CPOT), urinary retention (bladder scan), ventilator dyssynchrony (check ventilator settings, adjust flow/trigger), medications (akathisia from metoclopramide, steroids, dopamine agonist withdrawal), hypoglycemia, hypoxia, hypercarbia. Address the cause — don't reflexively sedate agitation.

8

Propofol has rapid on/off profile — preferred for titration

Propofol infusion has a rapid onset and short half-life enabling minute-to-minute RASS titration. It also allows clear cognitive windows during daily SAT. Disadvantages: hypotension at higher doses, propofol infusion syndrome (rare, >5 mg/kg/hr for >48h), hypertriglyceridemia. Not recommended for patients requiring enteral nutrition (caloric content).

Common Questions About Your Results

Evidence-Based Methodology

RASS published by Sessler et al. (Am J Respir Crit Care Med 2002) from 290 adult ICU patients. Inter-rater reliability ICC 0.956; validity against GCS and Ramsay Scale. PADIS Guidelines (Devlin et al., Crit Care Med 2018): RASS and SAS are recommended for routine ICU sedation monitoring. Deep sedation (RASS -3 to -5) and mortality: Shehabi et al. (JAMA 2012). ABC Bundle for ventilator liberation: Girard et al. (Lancet 2008).

Clinical Content Trust

Last reviewed:
April 21, 2026
Guideline version:
General evidence framework v2026.04
Source set version:
Primary-source set v1

How to Interpret Your Result

Positive RASS values indicate agitation severity, zero reflects alert calm status, and negative values indicate progressively deeper sedation. Very negative scores can limit neurologic assessment and delirium screening reliability.

When to Use This Tool

Use RASS during emergency and ICU care whenever monitoring mental arousal, titrating sedatives, or documenting agitation trends over time.

Limitations

RASS is observer-based and can vary by examiner technique. It reflects arousal state at one point in time and does not independently diagnose pain, delirium etiology, or neurologic injury.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

  1. April 21, 2026 · trust-baseline

    Clinical trust metadata enabled for this tool page with structured review/version fields.

Frequently Asked Questions